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A B S T R A C T
Background: Heart failure (HF) necessitates frequent transport by emergency medical services (EMS), but few
studies have been conducted to evaluate predictors of EMS use and of multiple EMS transports that are ame-
nable to intervention.
Objectives: To characterize prehospital clinical status of community-dwelling adults with reported HF who
used EMS across 8 years and to evaluate predictors of EMS use and multiple EMS transports.
Methods: Data were from a database in a large Midwestern county. Descriptive statistics, logistic and negative
binomial regression were used for analysis.
Results: EMS transports were evaluated for 6582 adults with 16,905 transports. The most common chief com-
plaints were respiratory problems, feeling sick, and chest pain. Shortness of breath, chest pain, level of con-
sciousness, age, gender, race, and hospital site predicted multiple transports.
Conclusions: Clinicians need to educate patients with HF about ways to manage shortness of breath and chest
pain and when to activate EMS.
© 2020 Elsevier Inc. All rights reserved.
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Symptoms
Heart failure (HF) is a serious chronic condition associated with
high mortality rates, frequent hospitalizations, and poor quality of
life. In the United States (U.S), the prevalence of HF is approximately
6.5 million and the annual incidence is approximately 1,000,000.1
The 12-month mortality rate is 29.6% and the 5-year mortality rate is
52.6% for adults with HF.1 It is a leading cause of hospitalization
among adults age 65 years and older,1 necessitating the need for pre-
hospital transport by emergency medical services (EMS). Healthcare
resource use is high among these adults. In the U.S. in 2015, the cost
of care for adults with HF was $11 billion.2 The total number of EMS
transports for HF is unclear but likely high. There were 958,167 visits,
on average, to emergency departments for acute decompensated
heart failure from 2006 to 2010 in the U.S. and these visits accounted
for 0.77% of all emergency department visits.3 In a study of patients
from Canada enrolled in the Acute Studies of Nesiritide in Decompen-
sated Heart Failure (ASCEND-HF), 27% of patients in the clinical trial
and 52% of patients in the registry arrived at hospitals by ambulance.4
National evidence-based clinical practice guidelines are available to
guide medical therapeutics for adults with HF.5,6 Evidence-based scien-
tific statements and best practices are available to coordinate care for
adults with HF as they transition from hospital to home and to improve
self-care for adults living in the community.7!9 However, adults with
HF continue to require frequent hospitalizations for acute decompen-
sated HF. In a past study, adults with HF reported delays in seeking
treatment for decompensation because of difficulties in interpreting
symptoms as emergent, urgent, or non-urgent.10 Ultimately, this delay
in seeking treatment may lead to increased mortality and morbidity
given the progressive decrement in left ventricular function due to
myocardial necrosis with each acute cardiac decompensating event.11
The prehospital phase of care, from activation of EMS to arrival at
the emergency department, is a critical window of time to implement
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life-saving treatments.12!14 Accurate assessment of the emergent sit-
uation is essential to directing initial care. The critical window of
time concept of ‘door-to-balloon’ is well characterized for adults with
acute coronary syndromes in which prehospital assessment and
treatment have led to rapid assessment and activation of the cardiac
catheterization team with improvements in diagnosis and out-
comes.13,14 Less data are available for adults with HF to determine if
there is a critical window of time in the prehospital phase for imple-
mentation of treatments that would improve diagnosis and survival
and reduce morbidity. In a consensus document on prehospital and
emergency care for acute HF, Mebazaa and colleagues12 recom-
mended treatments that should be implemented during the preho-
spital phase but noted that the recommendations are primarily based
on clinical judgment. Lack of empirical evidence regarding prehospi-
tal clinical status including presenting symptoms makes develop-
ment of a treatment algorithm difficult.
Although empirical evidence is lacking for prehospital clinical sta-
tus variables as predictors of mortality and morbidity, studies have
been conducted to evaluate predictors of inpatient and outpatient
mortality and re-hospitalization among patients with HF treated in
the emergency department. In past studies, predictors evaluated
included demographics, vital signs, laboratory values, and comorbid-
ities. Among samples of patients with HF, systolic blood pressure was
a predictor of mortality15!19 and combined mortality and rehospitali-
zation.17 Diastolic blood pressure was a predictor of mortality.19,20
Heart rate was a predictor of in-hospital mortality among patients
with HF.15,18,19 Compared with patients with HF who self-presented
to the emergency department, patients transported by EMS had
lower oxygen saturation levels.21 In other studies among patients
with HF, poorer cognitive function22,23 and breathlessness24 were
predictors of mortality. In univariate analyses among patients with
HF, presence of angina was significantly associated with mortality.24
Using real-time data collected at the point of care, the current
study was conducted to describe prehospital clinical status and treat-
ments administered to a large population of community-dwelling
adults with reported HF who were transported by EMS and to evalu-
ate predictors of EMS use and multiple EMS transports. Aim one was
to characterize the prehospital clinical status of and treatments and
medications administered to adults with HF who were transported
by EMS from home to one of three acute-care hospitals in a large
Midwestern county from July 1, 2009 through June 30, 2017. Aim
two was to evaluate predictors of EMS use and multiple EMS trans-
ports using clinical status variables associated with mortality and
hospitalization among adults with HF in past studies. The study was
designed to be hypothesis generating for future studies.
Methods
Design and data source
This observational study was approved by the university institu-
tional review board. The data were obtained from the electronic
health records of a single, large urban Midwestern county (Marion
County, Indiana, 2017 population 950,082)25 EMS program. In 2017,
this EMS agency employed 230 full-time emergency medical techni-
cians (EMTs) and paramedics. During peak on-duty times, there are
31 advanced life support-equipped ambulances in service to cover
261 square miles. In 2017, the EMTs and paramedics responded to
112,180 calls and delivered patients to 26 hospitals, four of which
had level 1 trauma centers. Medical direction is provided by faculty
physicians at Indiana University School of Medicine.
The EMS electronic health record had over 775,000 visits to peo-
ple needing transport from July 1, 2009 to June 30, 2017. The data in
the record are collected by the EMS personnel using the electronic
health record system based upon the National EMS Information Sys-
tem (NEMSIS) standard. The electronic health record has structured
categorizations that are completed by EMS personnel. EMS personnel
receive four hours of training prior to beginning employment. The
database is maintained by continuous analysis of system metrics. The
EMS medical directors designed the protocols for treatments.
Sample
The inclusion criteria were: (1) diagnosis of HF in the EMS elec-
tronic health record; (2) age 21 years and older; (3) EMS activated by
adult needing transport, family member, or bystander; and (4) trans-
ported by EMS to one of the three acute-care hospitals in the city
between July 1, 2009 and June 30, 2017. Records of all adults who
met the inclusion criteria were included in the study. There were no
exclusion criteria because the purpose of the study was to character-
ize all EMS transports of patients with HF.
Procedures
All transports of patients who met the inclusion criteria were
identified by the EMS Chief of Information Technology and Informat-
ics (co-author TPA) using the EMS electronic health records. As the
intent was a ‘real-world’ analysis, input from EMS providers was
taken at face value, similar to input from physicians, nurses, and
other clinicians into the hospital electronic health records. No study
specific abstraction was performed to compare accuracy. The data
retrieved from the electronic health records were downloaded by the
EMS Chief into a Microsoft Excel! data file. The data manager from
the university biostatistics division (co-author RC) converted the
Excel! file to statistical databases. The EMS Chief and data manager
verified the statistical databases for completeness and accuracy prior
to analysis by cross-checking Excel! and SPSS data in the files. Miss-
ing data were coded as missing and not included in analyses. The sta-
tistical databases were deidentified prior to analysis.
Measures
Demographic and clinical status variables were originally obtained
from the adults or family members by EMS paramedics and EMTs dur-
ing transport using structured categorizations: weight; chief complaint;
number of medications currently taking; presence or absence of atrial
fibrillation, cardiac pacemaker, implantable cardiac defibrillator; and
history of hypertension, coronary artery disease, coronary artery bypass
graft, HF, myocardial infarction, and sudden cardiac arrest. In addition,
clinical status variables obtained by the paramedics and EMTs included
the following: symptoms of shortness of breath, chest pain, and other
pain; vital signs of systolic and diastolic blood pressure, heart rate,
heart rhythm, respiratory rate, and temperature; oxygen saturation;
end-tidal carbon dioxide; and Glasgow Coma Scale.26 The Glasgow
Coma Score was developed to assess changes in level of conscious-
ness.26 Possible scores range from 3 to 15, with lower scores indicating
lower levels of consciousness. Scores of 13!15 suggest mild brain
injury, 9!12 suggest moderate brain injury, and 3!8 suggest severe
brain injury. Validity and reliability have been documented and the
overall score is correlated with mortality.
Treatments and medications administered were delivered and
documented by paramedics and EMTs. Types of treatments adminis-
tered were: airway maintenance; bleeding and burn care; cardiopul-
monary resuscitation; immobilization; medication management
(type, dosage, and route); oxygen therapy; and safety management.
Number of transports was obtained from the EMS database. The
EMS and study data managers identified the number of transports for
each patient in the database using the variables first name, last name,
age, and gender. The number of transports for each patient was
added as a variable in the statistical database before deidentifying it.
The first transport was considered the index transport for adults with
multiple transports.
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The six pre-specified independent predictor variables assessed at
the index EMS transport were: (1) blood pressure; (2) heart rate; (3)
oxygen saturation; (4) decreased level of consciousness; (5) shortness
of breath; and (6) chest pain. These variables predicted mortality and
hospitalization among patients with HF in past studies.15!24
Statistical analysis
All variable scores were examined for statistical outliers. Descrip-
tive statistics were computed for demographic and study variables.
To accomplish aim one, descriptive statistics were computed to char-
acterize the clinical status, chief complaints which included clinical
status variables such as respiratory problems and symptoms such as
chest pain, and treatments and medications administered for all
adults at the index transport and for all transports. To accomplish
aim two and evaluate predictors of multiple EMS transports, univari-
ate analyses (t-test and Chi-squared) were conducted to examine dif-
ferences between adults with one transport and with multiple
transports. Significant variables were entered into the logistic regres-
sion analyses as independent variables to evaluate predictors of mul-
tiple transports (i.e., one versus more than one).27,28 Models were
adjusted for age, gender, race, and receiving hospital. The odds ratios,
significance levels, and the confidence intervals were examined for
the six individual predictor variables. Negative binomial regression
was used to identify predictors of multiple transports following the
full distribution of the number of transports corrected for exact over-
dispersion. Negative binomial regression was used in the analysis of
the number of transports to account for overdispersion of these data.
Results from negative binomial regression are presented as incident
rate ratios and interpreted as the relative percent (%) increase in
number of transports. Data were analyzed using SAS! and Stata!.
The significance level was P < .05.
Results
The sample was 6582 adults with reported HF who had at least
one EMS transport from July 1, 2009 through June 30, 2017. Descrip-
tive and clinical characteristics are presented in Table 1. A majority of
adults (mean age 63.7 years) were women (57.6%) and reported race
as Black (57.7%). At the index transport, nearly two-thirds (65%) of
the adults had chest pain and nearly half (44.1%) had shortness of
breath (Table 1). Mean Glasgow Coma Scale score was 14.5, mean
systolic and diastolic blood pressures were 146.6 mmHg and
82.6 mmHg, respectively, and mean heart rate was 91.3 beats per
minute. Mean respiratory rate was 20.1 breaths per minute and
mean oxygen saturation was 94.7%.
The 6582 adults had a total of 16,905 transports. There was a range
between 1 and 80 transports per person. The median number of trans-
ports was 2 (inter-quartile range = 1!6; mean = 2.6 § 4.4 transports). A
majority of adults (60.6%) had one transport and the other adults had
two (15.9%), three (7.2%), four (4.2%), and five or more (12.1%) transports.
In terms of prehospital clinical status, adults had 28 different chief
complaints ranging from possibly mild complaints (e.g., headache) to
cardiac arrest. The three most frequent chief complaints at the index
transport were respiratory problems (28.8%), feeling sick (20.8%), and
chest pain (15.2%). All other chief complaints at index transport were
reported by fewer than 10% of the adults. Although less frequent,
there were numerous chief complaints for pain other than chest pain
(headache, abdominal, generalized), injuries (trauma/injury, burns,
poisoning/overdose), diabetic emergency, stroke, cardiac arrest, and
seizures. The most frequent chief complaints across all transports
were respiratory problems (26.6%), feeling sick (23%), and chest pain
(17%) (Fig. 1). The frequency was similar for chief complaints at index
transport and subsequent transports, with respiratory problems, feel-
ing sick, and chest pain accounting for approximately 80% of trans-
ports up to adults’ tenth transport (Fig. 1).
Descriptive statistics are presented for treatments and medications
administered during the index transport and all transports in Tables 2
and 3. During the index transports, 23 different types of treatments were
administered and a total of 12,885 treatments were administered. The
most frequent treatments were establishing intravenous/intraosseous
access (26.8%) and administering oxygen therapy (23.7%), medication
(23.1%), and intravenous fluid (14.8%). During all transports, a total of
38,079 treatments were administered. The most frequent treatments
were administering medications (37.1%), establishing intravenous/
intraosseous access (23.2%), administering oxygen therapy (20.8%), and
delivering intravenous fluid (11.4%). During the index transports, 29 dif-
ferent medications were administered and the most frequent medica-
tions were nitroglycerin (25.4%), albuterol (23.6%), aspirin (14.1%),
ipratropium bromide (15.7%), ondansetron (5.5%), and fentanyl (5.2%).
Medications were delivered by multiple routes, including oral, sublin-
gual, nasal, endotracheal tube, inhalation, intravenous, and intraosseous.
During all transports, the most frequent medications were nitroglycerin
(26.9%), albuterol (23.0%), aspirin (16.5%), ipratropium bromide (15.9%),
ondansetron (5.8%), and fentanyl (4.8%) and these medications were
delivered by the same routes as at the index transports.
Predictors of multiple transports are shown in Table 4. Among the
a priori selected predictors, chief complaints of shortness of breath
Table 1
Descriptive statistics for demographic and clinical status variables for adults at
index transport (N = 6582)a.
Variable n (%) or Mean § SD
Gender, (N = 6580)
Women 3792 (57.6%)
Men 2788 (42.4%)
Age in years 63.7 + 14.5
Race, (N = 6506)
Alaskan Native or American Indian 3 (0.0%)
Asian 6 (0.1%)
Black 3755 (57.7%)
Pacific Islander 1 (0.0%)
White 2695 (41.4%)
Other 46 (0.7%)
Ethnicity, (N = 6435)
Hispanic/Latino 60 (0.9%)
Not Hispanic/Latino 6375 (99.1%)
Weight in kg (N = 4918) 95.6 § 33.7
Number medications taking 6.4 § 5.3
Atrial fibrillation and/or atrial flutter 687 (10.4%)
Cardiac pacemaker 446 (6.8%)
Implantable cardioverter defibrillator 261 (4.0%)
Comorbid conditions
Hypertension 4967 (75.5%)
Coronary artery disease 750 (11.4%)
Coronary artery bypass graft 327 (5.0%)
Myocardial infarction 1161 (17.6%)
Sudden cardiac arrest 52 (0.8%)
Shortness of breath, (N = 5901) 2602 (44.1%)
Chest pain, (N = 5901) 3837 (65.0%)
Other pain, (N = 5901) 136 (2.3%)
Glasgow Coma Scale score (N = 6035) 14.5 § 2.0
End-title carbon dioxide, mm/Hg (N = 60) 34.6 § 22.5
Blood pressure, systolic, mm/Hg (N = 6513) 146.6 § 40.1
Blood pressure, diastolic, mm/Hg (N = 5512) 82.6 § 22.6
Heart rate (N = 6486) 91.3 § 25.3
Respiratory rate (N = 6472) 20.1 § 6.9
SpO2 level,% (N = 5438) 94.7 § 8.4
Temperature, degrees Fahrenheit (N = 253) 98.3 § 1.7
Number of EMS transports per patient
1 3986 (60.6%)
2 1049 (15.9%)
3 475 (7.2%)
4 277 (4.2%)
5 ! 80 795 (12.1%)
Abbreviations: EMS, Emergency Medical Services; SD, standard deviation.
a Actual sample size is indicated when number of total patients does not sum
to 6582 due to missing data.
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and chest pain and lower level of consciousness (i.e., lower Glasgow
Coma Scale scores) were significantly associated with greater odds of
having multiple transports. Significant covariates associated with
greater odds of having multiple EMS transports were age, gender,
race, and hospital site. Adults of younger age, female gender, and
Black race were more likely to have multiple transports.
Predictors of greater number of EMS transports are presented in
Table 4. Index chief complaints of shortness of breath, chest pain, and
higher oxygen saturation were associated with having significantly
more transports. For example, adults who had shortness of breath
during the index transport had 13.1% more transports compared
with adults who were otherwise similar. Significant covariates asso-
ciated with more EMS transports were age, gender, and hospital site.
Discussion
Results of this study are important because the prehospital clinical
status, chief complaints, and treatments and medications adminis-
tered were characterized for a large sample of community-dwelling
adults with reported HF transported from home to hospital by EMS
over 8 years and predictors of multiple transports were evaluated.
The chief complaint of respiratory problems was the most frequent
complaint at the index transport and across all transports, docu-
mented for more than one-fourth (26.6%) of all transports. The next
most frequent chief complaints were feeling sick (23%) and chest
pain (17%). Unexpectedly, chest pain was the most frequently
reported clinical status variable at the index transport and was docu-
mented for nearly two-thirds (65%) of the adults. Shortness of breath
was the second most frequently reported clinical status variable at
the index EMS transport, documented for 44.1% of the adults. The
finding was expected that respiratory problems would be the most
frequent chief complaint because dyspnea is a hallmark symptom of
HF decompensation. Collectively, these findings provide new insight
into the reasons why community-dwelling adults with reported HF
are transported by EMS. There is a need to improve our understand-
ing of these presenting chief complaints to develop and test preho-
spital interventions.
Fig. 1. Chief complaint across all transports.
Table 2
Treatments administered at index transport and at all transports.
Treatment Index transport (N %) All transports (N %)
Intravenous/intraosseous access 3448 (26.8%) 8830 (23.2%)
Intravenous fluid 1905 (14.8%) 4337 (11.4%)
Medical control 724 (5.6%) 1389 (3.6%)
Medication given 2970 (23.1%) 14,122 (37.1%)
Oxygen therapy 3051 (23.7%) 7939 (20.8%)
Ventilation 161 (1.2%) 299 (0.8%)
Equal to or less than 1% at index
and total transportsa
626 (4.9%) 1163 (3.1%)
Total treatments 12,885 38,079
a Basic life support airway care, Bleeding or burn care, Chest decompression, Clear
airway, Electrical therapy, Extrication, Extubation, Intubation, Patient positioning,
Restraints, Spinal immobilization, Splint, Start cardiopulmonary resuscitation, Stop
cardiopulmonary resuscitation, Suctioning, Surgical cricothyrotomy, Vagal maneuver.
Table 3
Medications administered at index transport and at all transports.
Medication Index transport (N %) All transports (N %)
Albuterol 1254 (23.6) 3237 (23.0)
Aspirin 747 (14.1) 2321 (16.5)
Atropine 59 (1.1) 81 (0.6)
Epinephrine 1:10,000 120 (2.3) 126 (0.9)
Fentanyl 274 (5.2) 673 (4.8)
Ipratropium bromide 833 (15.7) 2236 (15.9)
Nitroglycerin 1350 (25.4) 3787 (26.9)
Ondansetron 290 (5.5) 814 (5.8)
Equal to or less than 1% at index
and total transportsa
380 (7.2) 796 (5.7)
Total medications administered 5307 14,071
a Acetaminophen, Adenosine, Amiodarone, Calcium chloride, Dextrose 10%, Dex-
trose 50%, Diphenhydramine, Dopamine, Epinephrine 1:1000, Glucagon, Ketorolac,
Lidocaine, Magnesium sulfate, Methylprednisolone, Metoclopramide, Midazolam,
Morphine, Naloxone, Oral glucose, Prednisone, Sodium bicarbonate.
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It is noteworthy that chest pain was the most frequently reported
clinical status variable and the third most frequent chief complaint.
As such, the presenting chief complaints of these adults might con-
found assessment and initial approach to emergency care. In past
studies of treatment seeking delay among adults with HF, chest pain
was not often mentioned as a frequent symptom associated with
delay and EMS transport.4,29!32 Harjola reported that only 9% of the
patients who used EMS had chest pain.21 Sporer reported that nitro-
glycerin was administered to 93% of 319 patients with HF transported
by EMS, but it was unclear if the medication was administered for
actual chest pain or prophylaxis.32 In the current study, nitroglycerin
was the most frequently administered medication at 25.3% during
the index transports. Ekman and colleagues reported that self-
reported angina was significantly associated with all-cause hospitali-
zation and mortality among 3029 patients with HF.24 The etiology of
chest pain in HF may be the result of acute coronary syndrome or
high filling pressures of the left ventricle and demand ischemia.
Therefore, the increased mortality might be expected in these condi-
tions. Investigators examining health outcomes among adults with
HF need to conduct more comprehensive and frequent assessments
of chest pain and recognize its important prognostic implications and
need for therapy. Clinicians caring for patients with HF need to edu-
cate patients and family members about efficacious ways to assess
and manage chest pain on a routine and ongoing basis, including
when to seek urgent and emergency treatment.
In this study, the adults had 28 different chief complaints, reflect-
ing the complexity of the HF syndrome. These disparate complaints
represent a diagnostic challenge for determining adults’ primary
problem and identifying therapeutic targets for interventions. The
finding of multiple chief complaints of pain in different locations
(chest, headache, abdominal, back) is consistent with research con-
ducted by Goodlin and colleagues33 who investigated pain among
347 outpatients with advanced HF from clinics and hospices. The
prevalence of pain was 84.4% at any body site and interfered with
activity for 70% of these patients. Pain was reported as severe or very
severe for 28.6% of patients with chest pain and for 38.9% of patients
with pain at other sites and only opioid medications were reported
as providing relief. Degenerative joint disease, other types of arthritis,
shortness of breath, and angina pectoris were the strongest predic-
tors of pain. In a literature review conducted to evaluate the preva-
lence of pain in 65 studies among patients with HF, the prevalence of
pain ranged from 23 to 85%.34
Injuries were another group of chief complaints in this study that
triggered EMS activation. Injuries have received limited attention
among adults with HF. For example, adults with HF are at increased
risk of falls35,36 and associated fractures. Cerebellar damage has been
reported among adults with HF, which may be an etiology for falls.37
Research is needed to design and test safety interventions such as fall
prevention programs to prevent injury among adults with HF.
At the index and across all EMS transports, 23 different treatments
and 29 different medications were administered. The most frequent
treatments were establishing medication access routes, providing
oxygen therapy, and administering medications and intravenous flu-
ids. The most frequently administered medications were for chest
pain and shortness of breath. The most frequently administered med-
ication was nitroglycerin at index transport. These findings support
the need for future studies that more comprehensively assess and
manage pain among adults with HF in the community.
Index chief complaints of shortness of breath and chest pain and
poorer level of consciousness were predictors of multiple transports.
Index chief complaints of shortness of breath and chest pain and higher
oxygen saturation were predictors of number of transports. Younger
age, female gender, Black race, and hospital to which adults were taken
were significant covariates. Continued focus on management of short-
ness of breath and chest pain has potential to reduce EMS transports.
Strengths of this novel study were use of data obtained at the
point-of-care from a large, diverse population of community-dwell-
ing adults with a report of HF who used EMS services across 8 years.
In contrast to many studies among HF populations, this population
was comprised of more women than men and more Black patients
than White patients. The findings provide new knowledge about the
prehospital status of these adults who activated EMS that can be
used to design and test multi-level interventions to improve care and
outcomes among adults with HF.
Limitations of this study were lack of echocardiographic valida-
tion of the HF diagnosis and lack of data about non-cardiac comorbid
conditions. The lack of HF diagnosis validation is a common limitation
in prehospital studies for medical conditions such as HF that do not
have easily obtainable and reliable diagnostic tests for use in the
emergency field setting. The lack of data about non-cardiac comorbid
conditions prevented analysis of these conditions as predictors of
outcomes. A future study is needed to validate the reported HF diag-
nosis using emergency department or cardiologist diagnoses and
echocardiograms and to evaluate non-cardiac comorbid conditions as
Table 4
Predictive models of more than one transport and multiple transports.
Odds of More than One Transport Multiple Transports (in Percentage)
OR 95% CI p-value IRR 95%CI p-value
Age (in years) 0.992 (0.988!0.997) 0.003 0.988 (0.985!0.990) <0.001
Male Gender 0.836 (0.729!0.959) 0.011 0.929 (0.868!0.994) 0.032
Race*
Alaskan Native/Native American 2.048 (0.127!32.944) 0.613 0.808 (0.166!3.941) 0.792
Asian ! ! ! 1.108 (0.252!4.863 0.892
Black 1.284 (1.119!1.473) <0.001 1.070 (0.999!1.145) 0.050
Other 0.355 (0.111!1.134) 0.081 0.772 (0.459!1.297) 0.328
Not Hispanic/Latino 0.547 (0.211!1.413) 0.213 0.967 (0.620!1.507) 0.881
Receiving Facilityy
Hospital 1 1.269 (1.055!1.527) 0.012 1.311 (1.194!1.440) <0.001
Hospital 2 1.489 (1.215!1.825) <0.001 1.449 (1.308!1.606) <0.001
Systolic Blood Pressure (mm/Hg) 1.001 (0.998!1.003) 0.599 1.000 (0.999!1.002) 0.702
Diastolic Blood Pressure (mm/Hg) 0.999 (0.995!1.004) 0.765 1.000 (0.998!1.002) 0.954
Heart rate (bpm) 0.999 (0.998!1.003) 0.831 0.999 (0.998!1.001) 0.278
Sp02 (%) 1.009 (0.999!1.018) 0.079 1.008 (1.003!1.013) 0.002
Glasgow Coma Scale 1.067 (1.018!1.119) 0.007 1.019 (0.997!1.042) 0.098
Shortness of Breath (index transport) 1.177 (1.022!1.357) 0.024 1.131 (1.056!1.213) 0.001
Chest Pain (index transport) 1.160 (1.001!1.344) 0.048 1.150 (1.069!1.238) <0.001
OR, odds ratio; CI, confidence interval; IRR, incidence rate ratio.
* relative to White race.
y relative to Hospital 3.
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predictor variables. Another limitation was that was that adults may
have had more transports than analyzed in this study but data were
not obtained prior to 2009 and only three hospitals were included in
the analyses. Although using real-time data collected by multiple clini-
cians limited availability of data to validate diagnoses, the large amount
of data obtained at the point of care offered a unique opportunity to
investigate the actual prehospital status of adults and the treatments
and medications received. These data are hypothesis-generating and
can be used to guide design of prospective studies for validation of find-
ings and testingmulti-level interventions.
In conclusion, chest pain and respiratory problems were the most
frequent complaints among a large population of adults with
reported HF. Shortness of breath, chest pain, lower level of conscious-
ness, younger age, female gender, Black race, and hospital site pre-
dicted multiple transports across the 8 years of the study. Studies are
needed to determine the relationships between prehospital symp-
toms and treatments and short- and long-term outcomes after trans-
port. Assessments and interventions are needed to improve
management of chest pain among adults with HF. It needs to be
determined if the low flow state of decompensated HF triggers myo-
cardial ischemia among these adults. Interventions to relieve chest
pain may be particularly needed among younger adults, women,
adults of Black race, and adults with lower level of consciousness dur-
ing transport. Clinicians can use these findings to improve assess-
ment of adults and implement interventions to improve symptom
management, cardiovascular status, and health outcomes.
Disclosures
The authors have no relevant disclosures to report.
Acknowledgments
Indianapolis Emergency Medical Services for assistance with data
retrieval, Indiana University School of Nursing Office of Research Support
for data management, Center for Enhancing Quality of Life in Chronic Ill-
ness at Indiana University School of Nursing, and Ellen McAdams, BSW,
and Jia Lui, PhD, RN for assistance withmanuscript preparation.
References
1. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al.
Heart disease and stroke statistics—2018 update: a report from the American heart
association. Circulation. 2018;137(12):e67–492.
2. American Heart Association. Cardiovascular Disease: A Costly Burden for America !
Projections Through 2035. Washington DC: American Heart Association; 2017.
3. Storrow AB, Jenkins CA, Self WH, Alexander PT, Barrett TW, Han JH, et al. The bur-
den of acute heart failure on U.S. emergency departments. JACC Heart Fail. 2014;2
(3):269–277.
4. Ezekowitz JA, Podder M, Hernandez AF, Armstrong PW, Starling RC, O’Connor CM,
et al. Arrival by ambulance in acute heart failure: insights into the mode of presen-
tation from acute studies of nesiritide in decompensated heart failure (ASCEND-
HF). BMJ Open. 2016;6:(3) e010201.
5. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al.
2013 ACCF/AHA guideline for the management of heart failure: a report of the
American college of cardiology foundation/American heart association task force
on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239.
6. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2017 ACC/
AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management
of heart failure: a report of the American college of cardiology/American heart
association task force on clinical practice guidelines and the heart failure society of
America. Circulation. 2017;136(6):e137–e161.
7. Riegel B, Moser DK, Anker SD, Appel LJ, Dunbar SB, Grady KL, et al. State of the sci-
ence. Promoting self-care in persons with heart failure. A scientific statement from
the American heart association. Circulation. 2009;120(12):1141–1163.
8. Jurgens CY, Goodlin S, Dolansky M, Ahmed A, Fonarow GC, Boxer R, et al. Heart fail-
ure management in skilled nursing facilities: a scientific statement from the Amer-
ican heart association and the heart failure society of America. Circ Heart Fail.
2015;8(3):655–687.
9. Riegel B, Moser DK, Buck HG, Dickson VV, Dunbar SB, Lee CS, et al. Self-care for the
prevention and management of cardiovascular disease and stroke: a scientific
statement for healthcare professionals from the American heart association. J Am
Heart Assoc. 2017;6:(9) e006997.
10. Jurgens CY, Hoke L, Byrnes J, Riegel B. Why do elders delay responding to heart fail-
ure symptoms? Nurs Res. 2009;58(4):274–282.
11. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifesta-
tion of coronary artery disease. Circulation. 1998;97:282–289.
12. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, et al. Recom-
mendations on pre-hospital and early hospital management of acute heart failure:
a consensus paper from the heart failure association of the European society of car-
diology, the European society of emergency medicine and the society of academic
emergency medicine. Eur J Heart Fail. 2015;17(6):544–558.
13. Hemsey JK, Dracup K, Fleischmann K, Sommargren CE, Paul SM, Drew BJ. Prehospi-
tal electrocardiographic manifestations of acute myocardial ischemia indepen-
dently predict adverse hospital outcomes. J Emerg Med. 2013;44(5):955–961.
14. Z!egre-Hemsey JK, Sommargren CE, Asafu-Adjei JK, Drew BJ. Normal prehospital
electrocardiography is linked to long-term survival in patients presenting to the
emergency department with symptoms of acute coronary syndrome. J Electrocar-
diol. 2015;48(4):520–526.
15. AbrahamWT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH,
OPTIMIZE-HF Investigators and Coordinators. Predictors of in-hospital mortality in
patients hospitalized for heart failure: insights from the organized program to ini-
tiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-
HF). J Am Coll Cardiol. 2008;52:347–356.
16. Fonarow GC, Adams KF, AbrahamWT, Yancy CW, Boscardin WJ, ADHERE Scientific
Advisory Committee. Study Group, and Investigators. Risk stratification for in-hos-
pital mortality in acutely decompensated heart failure: classification and regres-
sion tree analysis. JAMA. 2005;293:572–580.
17. O’Connor CM, Abraham WT, Albert NM, Clare R, Stough WG, Gheorghiade M, et al.
Predictors of mortality after discharge in patients hospitalized with heart failure:
an analysis from the organized program to initiate lifesaving treatment in hospital-
ized patients with heart failure (OPTIMIZE-HF). Am Heart J. 2008;156:662–673.
18. Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, et al. on
behalf of the American heart association get with the guidelines-heart failure pro-
gram. Circ Cardiovasc Qual Outcomes. 2010;3:25–32.
19. Chioncel O, Collins SP, Greene SJ, Pang PS, Ambrosy AP, Antohi EL, et al. Predictors
of post-discharge mortality among patients hospitalized for acute heart failure.
Card Fail Rev. 2017;3(2):122–129.
20. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJV, Swedberg KB, et al. Predic-
tors of mortality and morbidity in patients with chronic heart failure. Eur Heart J.
2006;27:65–75.
21. Harjola P, Boyd J, Tarvasm€aki T, Mattila J, Koski R, Kuisma M, et al. The impact of
emergency medical services in acute heart failure. Int J Cardiol. 2017;232:222–226.
22. Pressler SJ, Kim J, Riley P, Ronis DL, Gradus-Pizlo I. Memory dysfunction, psycho-
motor slowing, and decreased executive function predict mortality in heart failure
patients with low ejection fraction. J Card Fail. 2010;16:750–760.
23. Zuccala G, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E, et al. The effects of
cognitive impairment on mortality among hospitalized patients with heart failure.
Am J Med. 2003;115:97–103.
24. Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA.
Symptoms in patients with heart failure are prognostic predictors: insights from
COMET. J Card Fail. 2005;11(4):288–292.
25. United States Census Bureau. Quick facts: Marion county, Indiana. https://www.
census.gov/quickfacts/XXXXXXX. 2017. (Accessed November 15, 2018.).
26. Teasdale G, Maas A, Lecky F, Manley G, Stocchetti N, Murray G. The Glasgow Coma
Scale at 40 years: standing the test of time. Lancet Neurol. 2014;13(8):844–854.
27. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing
models, evaluating assumptions and adequacy, and measuring and reducing
errors. Stat Med. 1996;15:e361–e387.
28. Hosmer DW, Lemeshow L. Applied Logistic Regression. 2nd ed. New York, NY:
Wiley; 2000.
29. Sethares KA, Sosa ME, Fisher P, Riegel B. Factors associated with delay in seeking care
for acute decompensated heart failure. J Cardiovasc Nurs. 2014;29(5):429–438.
30. Nieuwenhuis MM, Jaarsma T, Van Veldhuisen DJ, Van Der Wal MH. Factors associ-
ated with patient delay in seeking care after worsening symptoms in heart failure
patients. J Card Fail. 2011;17(8):657–663.
31. Johansson P, van der Wal M, van Veldhuisen DJ, Jaarsma T. Association between
prehospital delay and subsequent clinical course in patients with/hospitalized for
heart failure. J Card Fail. 2012;18(3):202–207.
32. Sporer KA, Tabas JA, Tam RK, Sellers KL, Rosenson J, Barton CW, et al. Do medica-
tions affect vital signs in the prehospital treatment of acute decompensated heart
failure? Prehosp Emerg Care. 2006;10(1):41–45.
33. Goodlin SJ, Wingate S, Albert NM, Pressler SJ, Houser J, Kwon J, et al. Investigating
pain in heart failure patients: the pain assessment, incidence, and nature in heart
failure (PAIN-HF) study. J Card Fail. 2012;18(10):776–783.
34. Alemzadeh-Ansari MJ, Ansari-Ramandi MM, Naderi N. Chronic pain in chronic
heart failure: a review article. J Tehran Univ Heart Cent. 2017;12(2):49–56.
35. Lee K, Titler M, Pressler SJ. Falls in patients with heart failure: a systematic review. J
Cardiovasc Nurs. 2016;31(6):555–561.
36. Pressler SJ, Jung M, Titler M, Lee K, Harrison J. Symptoms, nutrition, pressure
ulcers, and return to community among older women with heart failure at skilled
nursing facilities: a pilot study. J Cardiovasc Nurs. 2018;33(1):22–29.
37. Woo MA, Kumar R, Macey PM, Fonarow GC, Harper RM. Brain injury in autonomic,
emotional, and cognitive regulatory areas in patients with heart failure. J Card Fail.
2009;15(3):214–223.
ARTICLE IN PRESS
6 S.J. Pressler et al. / Heart & Lung 00 (2020) 1!6
